News from J&J, Teva and Amarantus – People on the move
in-PharmaTechnologist.com presents its weekly round-up of the latest new appoitnments within the world of pharma and biopharma including news from J&J, Teva and Amarantus.
Archives for November 12, 2012
Demand for bioavailability drove spray drying investment says Agere
Agere Pharmaceuticals has added spray drying to its offering, citing developer demand for bioavailability boosting technologies.
Boehringer withdraws Pradaxa lot after packaging line problems
Boehringer Ingelheim has withdrawn one lot of its anticoagulant Pradaxa in the US over concerns about defective packaging.
Boehringer set to make E.coli for clinical trials
Molecular Partners has contracted Boehringer Ingelheim to produce a range of highly potent molecules for its clinical pipeline.
Restart of Singapore plant project unlikely to affect Lonza deal, says Novartis
Novartis says the decision to reactivate plans for a biotechnology plant in Singapore is unlikely to affect its deal with Lonza.
Italy’s AIFA lifts ban on Novartis flu vaccines
Italian regulators have lifted a temporary ban on two Novartis flu vaccines in which high levels of protein aggregates were detected.
Report from PCT Europe
Is risk-based clinical trial monitoring too flexible for the regulators?
Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.